News

Feds recommend pausing vaccine for mosquito-borne disease chikungunya in people over 60
The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...
Becker's Hospital Review9h
FDA, CDC: Pause chikungunya shots in older adults
The FDA and CDC recommended a pause in administering Ixchiq, a chikungunya vaccine, in adults ages 60 and above after 17 serious adverse events, including two deaths.  About 80,000 Ixchiq doses have ...
Ada Derana14h
Spike in dengue and chikungunya cases in Sri Lanka
A total of 19,901 dengue cases have been reported in the country so far this year, according to the National Dengue Control ...
After 2 reported deaths, officials tell Ixchiq users age 60+ to stop vaccine temporarily
The Trump administration's FDA and CDC is advising U.S. patients using the drug Ixchiq to hold off while U.S. health ...
Chikungunya spreads in the US: 5 things doctors won't tell you about this bone-breaking disease
Most stories of chikungunya begin with something oddly harmless — a slight twitch in the toes or fingers. That’s when the ...
BioPharma Dive2d
FDA follows EMA in limiting use of Valneva shot
Reports of severe adverse events in some people who received the chikungunya vaccine have spurred regulators in Europe and ...
Explore more
Daily Mirror5d
Has Chikungunya been contained?
Despite health authorities issuing fresh guidelines to tackle the growing threat of Chikungunya, action on the ground tells a ...
Dengue, Chikungunya Cases Rise In Karnataka Ahead Of Monsoon, With Bengaluru Worst-Hit: Know Symptoms, Precautions
According to reports, a cause for concern is that 51 of the cases involve infants under one year of age, while 553 are among children under 18.